Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489**Org 32489, Organon International, Oss, The Netherlands.) in gonadotropin-deficient volunteers ††Supported by Organon International, Oss, The Netherlands.‡‡Presented in part at the 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, Texas, March 18 to 21, 1992.

Autor: Mannaerts, Bernadette, Shoham, Zeev, Schoot, Dick, Bouchard, Philip, Harlin, Jonas, Fauser, Bart, Jacobs, Howard, Rombout, Ferdy, Bennink, Herjan Coelingh
Zdroj: Fertility and Sterility; January 1993, Vol. 59 Issue: 1 p108-114, 7p
Abstrakt: To assess safety, pharmacokinetic, and pharmacodynamic properties of recombinant human follicle-stimulating hormone (FSH; Org 32489, Organon International, Oss, The Netherlands) after a single intramuscular injection in the buttock.
Databáze: Supplemental Index